Valmet's Record Third Quarter Is Mostly a Rehearsal for the Breakup

A 25% organic order surge and a record Q3 margin hand Thomas Hinnerskov the evidence he needs — but the demerger, not the quarter, is the real catalyst

VALMT.HE · Earnings Call · 2026-10-28

The quarter is the alibi; the split is the story

Valmet delivered the kind of third quarter that normally resets a narrative: orders of EUR 1.4 billion, up 25% organically, and comparable EBITA of EUR 169 million at a 12.4% margin — the best third quarter the company has produced. And yet the guidance was reiterated, not raised: net sales flat versus 2025, comparable EBITA flat or up. Management spent more oxygen on the strategic review than on the beat. “Orders received were EUR 1.4 billion and increased 25% organically... comparable EBITA reached EUR 169 million with a margin of 12.4%. This was a record third quarter result.” — Thomas Hinnerskov, President and CEO · 2026-10-28 That gap between a strong print and a flat guide is the whole tension here. Q3 was carried by large capital projects — more than EUR 550 million of Biomaterials capital orders — and the CEO was explicit that this is not a run-rate: "large capital projects are inherently lumpy." Meanwhile Q4 is still the quarter that decides the year, and the swing factor is service activity, not backlog conversion.

Services finally swung — and this time it was broad

The genuinely new thing in this report is not the capital wins; Valmet wins pulp and board projects most years. It is that Biomaterials Services grew 12% organically, reversing declines in the first half, and that the growth was not one product line or one geography. “What I think which also makes me — gives me good confidence is that it was actually broadly based, both geographically, but also across the different services that we are providing.” — Thomas Hinnerskov, President and CEO · 2026-10-28 The mechanism matters more than the print. Prior calls leaned on mill improvements and operating rates as the explanatory variables for service demand; both have largely fallen out of the curated keyword set this quarter. In their place sits the strategic frame of life cycle — the company's top keyword this quarter — and aftermarket, the installed-base argument that does not depend on anyone pouring a new greenfield foundation. Thomas put a number on why the service line is inflecting: capacity rationalisation has run its course in North America, so Valmet's own installed base is running harder. “Last year in '25, there was a lot of closures across — especially North America, was it roughly 19 million ton or something that closed. I think we had roughly 7.5 million of that. This year, another 7 million closed. We had less than 2 million of that. So that's a positive.” — Thomas Hinnerskov, President and CEO · 2026-10-28 That is a rare instance of a CEO quantifying an installed-base tailwind rather than a project pipeline. It also explains the one metric that killed the last two years: operating leverage in service volume drops through at a high rate once the fixed cost base is reset.

Where the money actually went: the reset cost base

The margin story is not pricing. The cost reduction programme under Lead the Way has cut the comparable SG&A base by EUR 85 million on a last-twelve-month basis, excluding the acquired Engineered Severe Service business. That, plus the Severn consolidation, is the bridge from EUR 1.4 billion of sales to a record Q3 profit. The cost-cutting theme is not unique to Valmet — cost reduction plans is a persistent advancer in the market's own price tape across this period, and every industrial in this reporting cycle is selling the same slide. What differentiates Valmet is that the savings are landing in the same quarter as a 12% organic service recovery, so the drop-through is visible rather than promised. Process Performance Solutions showed the shape: orders EUR 399 million including EUR 44 million from Severn, sales EUR 408 million, and a 20.2% margin. The one soft spot is honest and external — the Middle East situation has frozen projects and service access in Flow Control and the API gas-chromatography business, a drag the wider market is also flagging (Middle East situation ranks near the top of global keywords earlier this year).

The last 12-month book-to-bill ratio improved to 0.96 from 0.91 in the previous quarter. While it remains below 1, the direction is encouraging... roughly EUR 3.7 billion of the backlog to be recognized as net sales in the fourth quarter of '26 and during next year.
Pekka Rouhiainen, Investor Relations · 2026-10-28

Book-to-bill below 1 for a company that must replace the Arauco project — roughly EUR 500 million of revenue in 2026, about 70% complete, start-up in the second half of 2027 — is the arithmetic problem Q4 has to solve.

Paying for optionality before the answer is known

The most consequential line in the release is a EUR 10 million Q4 charge to make the two segments separable. That is a management team buying furniture for a house it has not yet decided to build. The strategic review, first announced this summer and still a top-three company keyword last quarter, has now moved from words to spend. “What we do now in Q4 is not going to impact negatively, I would say, run rate cost into the new year.” — Thomas Hinnerskov, President and CEO · 2026-10-28 The continuity with July is striking. Then, the hypothesis was explicitly a two-listed-company demerger with flow and automation kept together; nothing has changed except the balance-sheet question, where Thomas is deliberately non-committal about whether each entity gets refinanced or simply carved out of the existing debt stack. What has changed is that the group is now spending into the option while admitting it has not quantified the dis-synergies, the tax leakage, or the group-cost duplication. Gearing of 47% against a 50% target, net debt of EUR 1.2 billion and 1.78x net debt/EBITDA after Severn leave limited room for a split without a capital structure decision. “The purpose is to keep flow and automation together if such a separation should occur. That's the hypothesis.” — Thomas Hinnerskov, President and CEO · 2026-07-24 And the counter-argument is the same one it was in July: automation into the pulp and paper base once justified the combination, and that base is now less than a third of PPS customers. “There are also synergies between flow control and automation. And there's a much stronger overlap there in the customer segments or customer industries that they're serving than into the biomaterial.” — Thomas Hinnerskov, President and CEO · 2026-07-24

The verdict

Valmet is a EUR 5.9 billion industrial that just printed its best third quarter ever and declined to raise guidance. Both facts are true, and together they are the point: capital project wins in China and Asia Pacific are real but unforecastable, service is inflecting but from a low base with management explicitly refusing to extrapolate one quarter, and the cost base has been structurally reset. The upside optionality is the demerger; the cost is EUR 10 million a quarter and counting, with an answer promised no later than the February 4 financial statements review. Buy-side debate should shift from "is service growing?" — it is — to what multiple a standalone Process Performance Solutions deserves with 20% margins and bolt-on M&A capacity, and whether the residual biomaterials business, sitting on the MES acquisition and the world's largest installed base, can be valued on aftermarket rather than on lumpy capital orders. The quarter was good. The decision is what gets re-rated.